IP Verse

Acuitas Therapeutics competitive analysis

Loading summary...

Latest oppositions filed by Acuitas Therapeutics

Explore patent oppositions filed by Acuitas Therapeutics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2729126
Liposomes Having Useful N:P Ratio For Delivery Of Rna MoleculesGLAXOSMITHKLINESep 23, 2021

Latest patents of Acuitas Therapeutics opposed by its competitors

Explore Acuitas Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4013385
Jul 3, 2024Improved Lipid Nanoparticles For Delivery Of Nucleic Acids6

Latest publications and patents of Acuitas Therapeutics New

Explore the latest publications and patents granted to Acuitas Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Acuitas Therapeutics

EP4013385
Jul 3, 2024Improved Lipid Nanoparticles For Delivery Of Nucleic AcidsGranted And Under Opposition

Latest PTAB cases involving Acuitas Therapeutics

Discover the latest PTAB cases involving Acuitas Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Acuitas Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ACUITAS THERAPEUTICS16 - -
GLAXOSMITHKLINE29112812
NOVARTIS6422 - 21